Jeffrey Skolnik | Senior Vice President, Clinical Development
Inovio Pharmaceuticals

Jeffrey Skolnik, M.D. Senior Vice President, Clinical Development Dr. Skolnik leads INOVIO’s clinical development programs, focusing on HPV and immuno-oncology DNA medicines. He is a key member of the leadership team overseeing these global clinical assets.  Dr. Skolnik has held several leadership positions in Clinical Development and Medical Affairs for AstraZeneca, GSK, and TetraLogic Pharmaceuticals, for both early- and late-stage compounds. Dr. Skolnik is a pediatric hematologist/oncologist and is an adjunct associate professor at the University of Pennsylvania.